Previous Close | 23.23 |
Open | 23.23 |
Bid | 23.06 x 800 |
Ask | 23.80 x 800 |
Day's Range | 23.01 - 25.00 |
52 Week Range | 20.84 - 34.28 |
Volume | |
Avg. Volume | 1,614,011 |
Market Cap | 2.516B |
Beta (5Y Monthly) | 0.47 |
PE Ratio (TTM) | 25.86 |
EPS (TTM) | 0.94 |
Earnings Date | May 01, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 42.80 |
Subscribe to Yahoo Finance Plus to view Fair Value for CORT
Corcept Therapeutics ( NASDAQ:CORT ) Full Year 2023 Results Key Financial Results Revenue: US$482.4m (up 20% from FY...
Corcept (CORT) beats on both earnings and sales in the fourth quarter. The company also reiterates its previously provided guidance for 2024.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript February 15, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.28, expectations were $0.25. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Corcept […]